Diagnostic performance of weight loss to predict body fatness improvement in cardiac rehabilitation patients.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 23426557)

Published in J Cardiopulm Rehabil Prev on March 01, 2013

Authors

Quinn R Pack1, Juan Pablo Rodriguez-Escudero, Randal J Thomas, Ray W Squires, Lezlie Johnson, Virend K Somers, Francisco Lopez-Jimenez

Author Affiliations

1: Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Articles by these authors

Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet (2006) 8.61

Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure. N Engl J Med (2015) 8.61

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol (2007) 7.79

Effect of altitude on leptin levels, does it go up or down? J Appl Physiol (1985) (2008) 6.68

Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation (2008) 5.87

Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA (2003) 5.39

Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol (2008) 4.78

Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation (2002) 4.77

Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med (2005) 3.84

Association of atrial fibrillation and obstructive sleep apnea. Circulation (2004) 3.81

Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2. Neurology (2013) 3.70

Impaired endothelial function in persons with obstructive sleep apnoea: impact of obesity. Heart (2012) 3.36

Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review. Mayo Clin Proc (2007) 3.12

The scoring of respiratory events in sleep: reliability and validity. J Clin Sleep Med (2007) 3.07

Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity. Hypertension (2005) 3.07

Assessing adiposity: a scientific statement from the American Heart Association. Circulation (2011) 3.00

Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation (2003) 2.99

Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol (2007) 2.99

Atrial fibrillation and obesity--results of a meta-analysis. Am Heart J (2007) 2.86

Plasma homocysteine in obstructive sleep apnoea. Eur Heart J (2004) 2.85

Body mass index: a risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease. Circulation (2003) 2.77

Obstructive sleep apnea. Ann Intern Med (2005) 2.75

Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J (2009) 2.71

Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension (2011) 2.68

High leukocyte count is associated with peripheral vascular dysfunction in individuals with low cardiovascular risk. Circ J (2012) 2.61

Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity". J Am Coll Cardiol (2013) 2.61

Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol (2011) 2.50

Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease. Eur Heart J (2007) 2.38

Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality. Ann Intern Med (2015) 2.31

Sleep-disordered breathing and cardiovascular disease. Circulation (2003) 2.30

The national cholesterol education program diet vs a diet lower in carbohydrates and higher in protein and monounsaturated fat: a randomized trial. Arch Intern Med (2004) 2.24

Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation (2004) 2.21

Obstructive sleep apnea is associated with increased high-sensitivity cardiac troponin T levels. Chest (2012) 2.21

Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc (2004) 2.14

Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a presidential advisory from the American Heart Association. Circulation (2011) 2.05

Effects of experimental sleep restriction on caloric intake and activity energy expenditure. Chest (2013) 2.02

Leptin deficiency promotes central sleep apnea in patients with heart failure. Chest (2014) 1.99

Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community. Circulation (2011) 1.94

Sleep and cardiovascular disease. Curr Probl Cardiol (2005) 1.91

Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population. Nat Clin Pract Cardiovasc Med (2008) 1.84

Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest (2010) 1.79

Sleep-disordered breathing and cardiovascular risk. Sleep (2007) 1.77

Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apnea. Chest (2009) 1.75

Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failure. J Hypertens (2007) 1.74

Association between plasma adiponectin levels and unstable coronary syndromes. Eur Heart J (2006) 1.73

ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects. Eur Heart J (2007) 1.67

Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol (2004) 1.64

Differentiating between body fat and lean mass-how should we measure obesity? Nat Clin Pract Endocrinol Metab (2008) 1.61

C-344T polymorphism of the aldosterone synthase gene and blood pressure in the elderly: a population-based study. J Hypertens (2005) 1.61

Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol (2013) 1.60

Plasma brain natriuretic peptide in obstructive sleep apnea. Am J Cardiol (2004) 1.59

Activity-adjusted 24-hour ambulatory blood pressure and cardiac remodeling in children with sleep disordered breathing. Hypertension (2007) 1.56

Participation in cardiac rehabilitation and survival after coronary artery bypass graft surgery: a community-based study. Circulation (2013) 1.54

Heart failure after myocardial infarction: prevalence of preserved left ventricular systolic function in the community. Am Heart J (2003) 1.53

AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services endorsed by the American College of Chest Physicians, American College of Sports Medicine, American Physical Therapy Association, Canadian Association of Cardiac Rehabilitation, European Association for Cardiovascular Prevention and Rehabilitation, Inter-American Heart Foundation, National Association of Clinical Nurse Specialists, Preventive Cardiovascular Nurses Association, and the Society of Thoracic Surgeons. J Am Coll Cardiol (2007) 1.51

Normal vascular function as a prerequisite for the absence of coronary calcification in patients free of cardiovascular disease and diabetes. Circ J (2012) 1.51

Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol (2008) 1.50

Influence of preoperative lipid-lowering therapy on postoperative outcome in patients undergoing coronary artery bypass grafting. Am J Cardiol (2007) 1.50

Subepicardial adipose tissue and the presence and severity of coronary artery disease. Atherosclerosis (2005) 1.50

Independent association between obstructive sleep apnea and subclinical coronary artery disease. Chest (2008) 1.47

Rationale and design of the SERVE-HF study: treatment of sleep-disordered breathing with predominant central sleep apnoea with adaptive servo-ventilation in patients with chronic heart failure. Eur J Heart Fail (2013) 1.47

Effects of beta-blocker therapy on ventilatory responses to exercise in patients with heart failure. J Card Fail (2005) 1.46

Atorvastatin for prevention of atrial fibrillation recurrence following pulmonary vein isolation: a double-blind, placebo-controlled, randomized trial. Heart Rhythm (2011) 1.46

Interatrial pressure gradients during simulated obstructive sleep apnea: a catheter-based study. Catheter Cardiovasc Interv (2014) 1.45

Resting sympathetic outflow does not predict the morning blood pressure surge in hypertension. J Hypertens (2011) 1.45

Clinical evidence for a health benefit from cardiac rehabilitation: an update. Am Heart J (2006) 1.45

Advanced heart failure and nocturnal hypoxaemia due to central sleep apnoea are associated with increased serum erythropoietin. Eur J Heart Fail (2010) 1.44

Gene-specific paradoxical QT responses during rapid eye movement sleep in women with congenital long QT syndrome. Heart Rhythm (2010) 1.43

Sleep and the metabolic syndrome. Exp Physiol (2006) 1.43

Obesity, sleep apnea, and hypertension. Hypertension (2003) 1.41

Arterial baroreflex function and cardiovascular variability: interactions and implications. Am J Physiol Regul Integr Comp Physiol (2002) 1.40

Symbolic dynamics of heart rate variability: a probe to investigate cardiac autonomic modulation. Circulation (2005) 1.39

Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999-2004. J Am Geriatr Soc (2013) 1.38

Obstructive sleep apnea: implications for cardiac and vascular disease. Chest (2008) 1.36

The comparative effectiveness of heart disease prevention and treatment strategies. Am J Prev Med (2009) 1.36

Trends in 10-year predicted risk of cardiovascular disease in the United States, 1976 to 2004. Circ Cardiovasc Qual Outcomes (2009) 1.35

Exercise training and cardiac rehabilitation in primary and secondary prevention of coronary heart disease. Mayo Clin Proc (2009) 1.33